This public procurement contract involves the continuous supply of medications containing anastrozole, enzalutamide, and tamoxifen over a period of 4 years, based on the current needs of the contracting authority. The total value of the contract is approximately 134.42 million CZK. The buyer is the
Tender closed on 6 Jun 2025. Awaiting award.
No single supplier dominates the field.
In healthcare medical, FACULTY HOSPITAL HRADEC KRLOV has awarded 35 contracts to 21 suppliers.
+15 more suppliers
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This public procurement contract involves the ongoing supply of medications containing palopegteriparatide for a duration of 4 years, based on the current needs of the contracting authority. The total value of the contract is 79,200,000 CZK. Suppliers are invited to provide these essential health pr
This public procurement contract involves the construction of a new standalone building for the Hradec Králové Hospital, specifically designed for the Infectious Diseases Clinic and the Dermatology Clinic. The project includes the relocation of utility networks, construction of ground, transport, an
This public procurement contract involves the ongoing supply of medicinal products containing povidone-iodine (ATC D08AG02) for a duration of 4 years, based on the current needs of the contracting authority. The total value of the contract is approximately 2,362,662.60 EUR. Suppliers are invited to
This public procurement contract involves the ongoing supply, installation, and configuration of blade server technology, including necessary accessories, as well as the provision of technical and post-warranty support. Additionally, the contract includes the installation of software defined by the
Innovate UK is investing up to £25.4 million to help develop and test early cancer diagnostic technologies, particularly for less common cancers, with projects costing £1.5-£4 million over 24-36 months.
Innovate UK is offering up to £25.4 million to fund collaborative projects that clinically validate innovative early cancer diagnostic technologies and devices led by UK organisations including at least one SME.
UKHSA seeks supplier information for Doxycycline 10-pack supply through a preliminary market engagement exercise under the Procurement Act 2023.
Suppliers are invited to complete a preliminary market engagement questionnaire about patient diagnostic and monitoring electrodes by 21st September 2026 through eTendersNI.
